Regentis Biomaterials Ltd. (RGNT NYSE) stock market data APIs
$1.8765
0.03(1.6%)
as of September 14, 2026
Try our APIs with
free plan!
Regentis Biomaterials Ltd. Financial Data Overview
Price chart is built with
Anychart
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.
Prev. Close
1.8765
Open
1.9027
High
1.9635
Low
1.8696
52 wk Range
1.232-9.4
Market Cap
13 205 K
Shares Outstanding
7 024 K
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Regentis Biomaterials Ltd. data using free add-ons & libraries
Get Regentis Biomaterials Ltd. Fundamental Data
Regentis Biomaterials Ltd. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: -23
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Regentis Biomaterials Ltd. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Regentis Biomaterials Ltd. News
New
Top Biotech Gainers: CANF Climbs, RGNT Gears Up For Europe Launch, RNAZ, ELTX On Watch
(RTTNews) - Today's leading biotech gainers include Can-Fite, following an update from its pancreatic cancer study; SeaStar Medical, driven by improving quarter-over-quarter revenue for its flagship p...
Regentis Biomaterials to raise $6.5M via private placement
* Regentis Biomaterials (RGNT [https://seekingalpha.com/symbol/RGNT]) said Wednesday it has agreed to raise ~$6.5 million in gross proceeds through a private placement of ordinary shares and accompa...
This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin Valuation
Dividends binder by Elena_Dig via Shutterstock The news of a deal between the U.S. and Iran to reopen the Strait of Hormuz sent markets higher yesterday. The S&P 500 and Nasdaq Composite gained 1.65%...
Top Biotech Gainers: RGNT Withdraws F-1 Filing, FDA Clears CUPR's Maggot Therapy, MYO On Watch
(RTTNews) - Today's top gainers include Regentis, amid developments including its withdrawal of a planned U.S. listing application (Form F-1) with the SEC; Cuprina, following FDA clearance for its mag...
Get Regentis Biomaterials Ltd. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
